Vanderbilt Tuberculosis Center


NIH renews grant support of RePORT-Brazil

5 Years - $5 Million


The Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network has been renewed. The new grant will support a team of more than 60 Brazil- and U.S.-based investigators who enroll people in Brazil with active and latent TB.
RePORT-Brazil is led by principal investigators Timothy Sterling, MD, holder of the David E. Rogers Professorship in the Department of Medicine and founding director of the Vanderbilt Tuberculosis Center, and Bruno Andrade, MD, PhD, of the Gonçalo Moniz Institute in Salvador, Brazil.
There were more than 10 million new cases of TB worldwide in 2021 and 1.6 million people died from the disease, according to the World Health Organization, making TB the world’s 13th leading cause of death and the second leading infectious diseases killer after COVID-19. Data collected through the RePORT-Brazil network has provided the foundation for numerous sponsored projects exploring drug resistance, TB/HIV, latent TB, transmission and pathogenesis, and treatment and prevention. It has also resulted in approximately 40 publications to date.
With funding from the NIH and Brazil’s Ministry of Health, RePORT-Brazil was established in 2013 as a partnership between five study sites in Brazil — three in Rio de Janeiro, one in Salvador, one in Manaus — with VUMC serving as the coordinating center. Brazil’s Ministry of Health is also providing new funding for the project.

Check out the announcement article on VUMC Reporter!

Get to know the RePORT-Brazil sites and team here:
Follow us on Twitter!
Twitter
Subscribe to our email list.